Galectin Therapeutics Inc. (GALT) vs SIGA Technologies, Inc. (SIGA)
A side-by-side comparison of Galectin Therapeutics Inc. and SIGA Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GALT
Galectin Therapeutics Inc.
$3.74HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
SIGA
SIGA Technologies, Inc.
$3.27HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — GALT vs SIGA
growth of $100 · dividends reinvested · last 10yGALT +166.4% (+10.3%/yr)SIGA +74.3% (+5.7%/yr)GALT compounded faster over this window
GALT SIGA
GALT vs SIGA: by the numbers
- •GALT is the larger company ($246M vs $234M market cap).
- •Both run net losses; GALT's is the smaller (0.00% vs -5.14% net margin).
- •SIGA pays a dividend (18.05% yield), while GALT has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | GALT | SIGA |
|---|---|---|
| Forward P/E | N/A | 1.92 |
| P/S ratio | N/A | 4.36 |
| P/B ratio | N/A | 1.42 |
Profitability
| Metric | GALT | SIGA |
|---|---|---|
| Gross margin | 0.00% | 68.57% |
| Operating margin | 0.00% | 25.05% |
| Net margin | 0.00% | -5.14% |
| ROE | N/A | -1.67% |
| ROIC | -1718.59% | -6.63% |
Dividends
| Metric | GALT | SIGA |
|---|---|---|
| Dividend yield | N/A | 18.05% |
Growth (annualized)
| Metric | GALT | SIGA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -10.88% |
| EPS CAGR (5Y) | N/A | -14.21% |
| Total return CAGR (5Y) | 0.60% | -6.59% |
Frequently asked
- Does GALT or SIGA pay a bigger dividend?
- SIGA pays a dividend (18.05% yield), while GALT has no payments in the available dividend history.
- How have GALT and SIGA total returns compared?
- Over the past 10 years, GALT delivered 13.41% and SIGA delivered 5.71% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
SIGA Technologies dividend yieldGalectin Therapeutics ROESIGA Technologies ROEGalectin Therapeutics operating marginSIGA Technologies operating marginGalectin Therapeutics revenue growthSIGA Technologies revenue growthGalectin Therapeutics free cash flowSIGA Technologies free cash flow
Galectin Therapeutics & SIGA Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.